BenevolentAI
BAI
Performance
About BenevolentAI
BenevolentAI is a biopharma AI company focused on applying advanced artificial intelligence to accelerate drug discovery and life sciences research. The company combines science and technology, leveraging a knowledge graph and proprietary ontologies to support scientists and executives in making data-driven, high-confidence R&D decisions. It positions itself as a pioneer in life science intelligence with global operations in biopharma innovation and drug discovery, including partnerships and activities in Luxembourg and beyond.
Recent News
Meta Director Appointed as Definely Executive
Deep Generative Molecular Design and Its Value in Modern Drug Discovery (Paper Feb 26)
Isomorphic Labs Pulls $2.1B Series B Led By Thrive With MGX, Temasek, And UK Sovereign AI Fund: What The Capital Stack, IsoDDE Engine, And Novartis/Lilly/J&J Partnerships Mean For Drug Discovery
Recent Deals
No recent deals for this company.